# CYCLOPHOSPHAMIDE
> **ANDA216783** · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2024-10-29
## Drug
- **FDA Application Number:** ANDA216783
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYCLOPHOSPHAMIDE
- **Generic name:** CYCLOPHOSPHAMIDE
- **Active ingredients:** CYCLOPHOSPHAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** NEXUS
- **Manufacturer:** Nexus Pharmaceuticals, LLC
- **First approval:** 2024-10-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216783)
---
*AI Analytics · CC0 1.0*